| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/10/2006 | CA2596967A1 Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2593858A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | CA2593857A1 Amino-pyridines as inhibitors of .beta.-secretase |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
| 08/09/2006 | EP1688041A1 An agricultural and horticultural disease controller and a method for controlling the diseases |
| 08/09/2006 | EP1687301A1 Thiaepothilone for treating cancerous diseases |
| 08/09/2006 | EP1687300A1 Process for the preparing ziprasidone monohydrochloride hydrate |
| 08/09/2006 | EP1687299A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treamtment and/or prevention of disorders modulated by a ppar |
| 08/09/2006 | EP1687294A2 Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 08/09/2006 | EP1687285A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 08/09/2006 | EP1686999A1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 08/09/2006 | EP1686996A1 Quinazolinone compounds with reduced bioaccumulation |
| 08/09/2006 | EP1560822B1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | CN1816550A Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators |
| 08/09/2006 | CN1816549A Inhibitors of phosphatidylinositol 3-kinase |
| 08/09/2006 | CN1816548A Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816531A Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/09/2006 | CN1816514A Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
| 08/09/2006 | CN1816332A 3-aminomethyl-pyrrolidines as N-type calcium channel blockers |
| 08/09/2006 | CN1814599A Thiazolidinedione derivative and its use as antidiabetic |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/09/2006 | CN1268626C Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/08/2006 | US7087761 Cyclic thiourea and acetylthiourea derivatives of benzothiazole for drugs |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087638 Plant safening agents; |
| 08/08/2006 | US7087635 3-substituted oxindole β3 agonists |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087629 Useful activity against Gram-positive pathogens and, in particular, against various strains exhibiting resistance to vancomycin and against E. faecium strains resistant to both aminoglycosides and clinically used beta-lactams |
| 08/08/2006 | US7087623 Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087611 Reacting ziprasidone with hydrochloric acid in solvent; salt formation; drying |
| 08/08/2006 | US7087610 Aids therapy |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087602 Cinnoline derivatives and use as medicine |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087598 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | CA2289512C 1,2,3-thiadiazole derivatives, plant disease controller and method for using the same |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080287A1 2-azolylimino-1,3-thiazine derivative |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006080025A1 Process for ziprasidone using novel intermediates |
| 08/03/2006 | WO2006079556A2 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | WO2006079504A2 Process for the manufacture of a precursor of vitamin b1 |
| 08/03/2006 | WO2006065480A3 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 08/03/2006 | WO2006061638A3 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 08/03/2006 | WO2006055708A3 Heterocycle substituted carboxylic acids for the treatment of diabetes |
| 08/03/2006 | WO2006032893A3 Trityl derivatives for enhancing mass spectrometry |
| 08/03/2006 | WO2005095361A8 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 08/03/2006 | WO2003072033A3 Common ligand mimics: thiazolidinediones and rhodanines |
| 08/03/2006 | US20060173198 Synthesis of dimeric, trimeric, tetrameric, pentameric, and higher oligomeric epicatechin-derived procyanidins having 4beta,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest |
| 08/03/2006 | US20060173183 Multicyclic bis-amide MMP inhibitors |
| 08/03/2006 | US20060173057 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173055 Pyrrole compounds useful as kinase inhibitors |
| 08/03/2006 | US20060173054 Treating Alzheimer's disease; e.g. 2',3',4',5,5',6,7,8,9,10-Decahydro-2-(5-(4-fluorophenyl)-1-methyl-pyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-(1,2,5)thiadiazole)-1',1'-dioxide |
| 08/03/2006 | US20060173047 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 08/03/2006 | US20060173046 Hydroxypyridine cgrp receptor antagonists |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173022 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
| 08/03/2006 | US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/03/2006 | US20060173008 New pyridazin-3(2h)-one derivatives |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172999 2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-phenyl-tetrahydropyran-4-yl]methyl-2-oxa-8-aza-spiro[4,5]decan-4-ol; neurokinin 1 (NK-1) receptor antagonists; antidepressant, anxiolytic, analgesic, antiinflammatory agent; migraine, emesis or postherpetic neuralgia |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060172984 Methods and compositions of novel triazine compounds |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | US20060172358 Novel chemiluminescent compounds and their use |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2595958A1 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |
| 08/02/2006 | EP1686128A2 Isothiazole derivatives and their use as pesticides |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685118A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 08/02/2006 | EP1685116A1 Quinazoline derivatives |
| 08/02/2006 | EP1685110A1 Octahydrophenanthrene hydrazide derivatives useful as glucocorticoid receptor modulators |
| 08/02/2006 | EP1685109A2 Amide compounds as ion channel ligands and uses thereof |
| 08/02/2006 | EP1685105A1 Allosteric modulators of metabotropic glutamate receptors |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
| 08/02/2006 | EP1684757A1 Substituted piperidines for the treatment of metabolic syndrome |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1684744A2 Pyrrolidine and piperidine derivatives as factor xa inhibitors |